In the pre-frontal cortex of individuals with AD, RNA editing of the GluA2 subunit of the AMPA receptor leads to alterations in intracellular Ca2+ levels, which are associated with neuronal dysfunction and neurodegeneration stemming from increased Ca2+ permeability [85]. This evidence concerns the gene GRIA2 and Alzheimer disease.